Back to top
more

Medtronic (MDT)

(Real Time Quote from BATS)

$89.32 USD

89.32
105,890

-0.35 (-0.39%)

Updated Aug 6, 2025 10:00 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Should Value Investors Consider Medtronic (MDT) Stock Now?

by Zacks Equity Research

Let's see if Medtronic plc (MDT) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

    Sweta Jaiswal headshot

    Can Boston Scientific's Pain be a Boon for Edwards & Others?

    by Sweta Jaiswal

    Boston Scientific delaying the re-introduction of Lotus Valve devices provides an edge to its competitors in the highly lucrative TAVR market.

      Zacks Equity Research

      Medtronic PLC (MDT) Down -2.1% Since Earnings Report: Can It Rebound?

      by Zacks Equity Research

      MDT reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.

        Zacks Equity Research

        Medtronic (MDT) Announces Positive Results on AdaptivCRT

        by Zacks Equity Research

        Medtronic (MDT) is consistently trying to improve its Cardiac Rhythm and Heart Failure division.

          Zacks Equity Research

          Medtronic's (MDT) Guardian Connect CGM System Wins FDA Nod

          by Zacks Equity Research

          Medtronic (MDT) continues to add initiatives to bolster the Diabetes segment.

            Zacks Equity Research

            Medtronic's Positive Study Results May Boost CSH Business

            by Zacks Equity Research

            Medtronic, (MDT) presenting favorable results from the studies based on the CoreValve TAVR system might boost the top line, with increased uptake of the product.

              Zacks Equity Research

              Laborie Medical Technologies to Acquire Cogentix Medical

              by Zacks Equity Research

              Laborie Medical Technologies will buy all of the outstanding shares of Cogentix Medical (CGNT) for a net worth of $239 million.

                Zacks Equity Research

                Medtronic's Guardian Sensor 3 With MiniMed 670G Wins FDA Nod

                by Zacks Equity Research

                Medtronic (MDT) advances with initiatives to boost the performance of its MiniMed portfolio.

                  Zacks Equity Research

                  Abbott to Strengthen Vascular Care Arm With Surmodics Deal

                  by Zacks Equity Research

                  Abbott (ABT) gains traction from its newly acquired rights over the SurVeil drug-coated balloon, which shows greater potential for capturing the market compared with traditional devices.

                    Zacks Equity Research

                    Medtronic (MDT) Expands in the U.S. with 2.0mm DES Launch

                    by Zacks Equity Research

                    Medtronic (MDT) consistently focuses on boosting CSH segment.

                      Zacks Equity Research

                      Cardinal Health Strong on Medical & Pharmaceutical Segments

                      by Zacks Equity Research

                      Cardinal Health (CAH) gains large number of Pharmaceutical Distribution customers.

                        Zacks Equity Research

                        Medtronic (MDT) Unveils MiniMed Mio Advance Infusion Set

                        by Zacks Equity Research

                        Medtronic (MDT) continues to adopt initiatives to drive the performance of its Diabetes segment.

                          Zacks Equity Research

                          United Therapeutics (UTHR) Q4 Earnings Decline on High Costs

                          by Zacks Equity Research

                          United Therapeutics' (UTHR) earnings per share decline in Q4 due to higher operating costs. Shares sink almost 10%.

                            Zacks Equity Research

                            Medtronic (MDT) Beats on Q3 Earnings, Reiterates FY18 View

                            by Zacks Equity Research

                            Medtronic (MDT) rides high on strength in all business segments in Q3.

                              Zacks Equity Research

                              Medtronic (MDT) Beats Q3 Earnings and Revenues Estimates

                              by Zacks Equity Research

                              Medtronic (MDT) gains on solid contributions from all business segments in Q3.

                                Zacks Equity Research

                                Medtronic's Positive Study Results May Expand Customer Base

                                by Zacks Equity Research

                                Medtronic (MDT) leaves no stone unturned to boost the performance of its Diabetes business.

                                  Zacks Equity Research

                                  Can CVG Boost Medtronic's (MDT) Q3 Earnings Once Again?

                                  by Zacks Equity Research

                                  New therapies within CVG should help Medtronic???s (MDT) Q3 gain traction in the rapidly growing markets for LVAD, TAVR, drug-coated balloons, atrial fibrillation and insertable diagnostics.

                                    Zacks Equity Research

                                    Boston Scientific's (BSX) Millipede Deal Aids MR Business

                                    by Zacks Equity Research

                                    Boston Scientific (BSX) claims the Millipede IRIS annuloplasty ring to be highly customizable to a specific patient's anatomy and disease state.

                                      Zacks Equity Research

                                      Medtronic's FDA Nod for Riptide Aspiration System Boosts RTG

                                      by Zacks Equity Research

                                      Medtronic (MDT) makes efforts to boost RTG business.

                                        Zacks Equity Research

                                        Medtronic (MDT) Wins FDA Nod for New Clinician Programmer

                                        by Zacks Equity Research

                                        Medtronic's (MDT) latest FDA nod likely to boost Pain Therapies division.

                                          Zacks Equity Research

                                          Medtronic's ITB Therapy Superior to CMM for PSS Reduction

                                          by Zacks Equity Research

                                          Medtronic (MDT) consistently tries efforts to boost Pain Therapies division, part of the Restorative Therapies Group.

                                            Zacks Equity Research

                                            Surmodics (SRDX) Poised on Core Business Amid Forex Woes

                                            by Zacks Equity Research

                                            Surmodics' (SRDX) top line benefits from strong sales in Medical Device and IVD businesses. However, foreign currency is a headwind.

                                              Zacks Equity Research

                                              Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings?

                                              by Zacks Equity Research

                                              AngioDynamics (ANGO) to gain from solid product portfolio and demand for Solero MTA system. However, unfavorable estimates are a concern.

                                                Mark Vickery headshot

                                                Top Analyst Reports for Comcast, Medtronic & Eni

                                                by Mark Vickery

                                                Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), Medtronic (MDT) and Eni (E).

                                                  Zacks Equity Research

                                                  Medtronic (MDT) Down 1.5% Since Earnings Report: Can It Rebound?

                                                  by Zacks Equity Research

                                                  Medtronic (MDT) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.